{"id":5512,"date":"2023-08-28T11:34:01","date_gmt":"2023-08-28T10:34:01","guid":{"rendered":"https:\/\/els-solutions.com\/cms\/dev\/?p=5512"},"modified":"2024-02-20T16:24:08","modified_gmt":"2024-02-20T16:24:08","slug":"infarmed-authorized-innovative-medicine-for-several-types-of-cancer","status":"publish","type":"post","link":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/","title":{"rendered":"Infarmed authorized innovative medicine for several types of cancer"},"content":{"rendered":"<\/p>\n<p><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">Infarmed, the Portuguese Medicines and Health Products Authority, has authorized the use of the medicine pembrolizumab for the treatment of metastatic triple negative breast cancer, metastatic colorectal cancer, persistent cervical cancer, metastatic oesophageal cancer, renal cell carcinoma in adults and some cases of melanoma. <a href=\"https:\/\/bit.ly\/3OpAWAy\">Read more here<\/a><\/span><\/p>\n<p><span class=\" author-d-iz88z86z86za0dz67zz78zz78zz74zz68zjz80zz71z9iz90z9z84zmz66zz71znz68znz69zz87z3z89zhz65zz89zybhz84zz79zkwtz79zsz76zdz122zjz80z7\">ELS can and will help you develop your new medicine, carry out feasibility studies and get your product regulated. If you would like to know more, p<\/span>lease contact your <a href=\"https:\/\/els-solutions.com\/en\/where-are-we\/\"><span class=\"s1\">ELS local consultant <\/span><\/a>or through the email: <a href=\"mailto:info@elssolutions.pt\"><span class=\"s2\">info@elssolutions.pt<\/span><\/a><\/p>\n<p>\n","protected":false},"excerpt":{"rendered":"<p>Pembrolizumab can be used, among others in the treatment of metastatic triple negative breast cancer.<\/p>\n","protected":false},"author":9,"featured_media":5508,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_joinchat":[],"footnotes":""},"categories":[54,61],"tags":[62],"class_list":["post-5512","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general","category-news","tag-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Infarmed authorized Medicine for several types of cancer<\/title>\n<meta name=\"description\" content=\"Infarmed has authorized the use of the medicine pembrolizumab for the treatment of several types of cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Infarmed authorized innovative medicine for several types of cancer\" \/>\n<meta property=\"og:description\" content=\"Pembrolizumab can be used, among others in the treatment of metastatic triple negative breast cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"ELS Group - Accelerating Innovation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/els.solutions\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-08-28T10:34:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-20T16:24:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Marketing ELS\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Marketing ELS\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\"},\"author\":{\"name\":\"Marketing ELS\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\"},\"headline\":\"Infarmed authorized innovative medicine for several types of cancer\",\"datePublished\":\"2023-08-28T10:34:01+00:00\",\"dateModified\":\"2024-02-20T16:24:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\"},\"wordCount\":818,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png\",\"keywords\":[\"News\"],\"articleSection\":[\"General\",\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\",\"url\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\",\"name\":\"Infarmed authorized Medicine for several types of cancer\",\"isPartOf\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png\",\"datePublished\":\"2023-08-28T10:34:01+00:00\",\"dateModified\":\"2024-02-20T16:24:08+00:00\",\"description\":\"Infarmed has authorized the use of the medicine pembrolizumab for the treatment of several types of cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png\",\"width\":1200,\"height\":600,\"caption\":\"Infarmed Innovative Cancer Medicine\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/els-solutions.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Infarmed authorized innovative medicine for several types of cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/els-solutions.com\/en\/#website\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"name\":\"ELS Group - Accelerating Innovation\",\"description\":\"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica\",\"publisher\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/els-solutions.com\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/els-solutions.com\/en\/#organization\",\"name\":\"ELS Group - Accelerating Innovation\",\"url\":\"https:\/\/els-solutions.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"contentUrl\":\"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png\",\"width\":2226,\"height\":1080,\"caption\":\"ELS Group - Accelerating Innovation\"},\"image\":{\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/els.solutions\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3\",\"name\":\"Marketing ELS\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g\",\"caption\":\"Marketing ELS\"},\"sameAs\":[\"https:\/\/els-solutions.com\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Infarmed authorized Medicine for several types of cancer","description":"Infarmed has authorized the use of the medicine pembrolizumab for the treatment of several types of cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Infarmed authorized innovative medicine for several types of cancer","og_description":"Pembrolizumab can be used, among others in the treatment of metastatic triple negative breast cancer.","og_url":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/","og_site_name":"ELS Group - Accelerating Innovation","article_publisher":"https:\/\/www.facebook.com\/els.solutions\/","article_published_time":"2023-08-28T10:34:01+00:00","article_modified_time":"2024-02-20T16:24:08+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png","type":"image\/png"}],"author":"Marketing ELS","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Marketing ELS","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#article","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/"},"author":{"name":"Marketing ELS","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3"},"headline":"Infarmed authorized innovative medicine for several types of cancer","datePublished":"2023-08-28T10:34:01+00:00","dateModified":"2024-02-20T16:24:08+00:00","mainEntityOfPage":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/"},"wordCount":818,"commentCount":0,"publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"image":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png","keywords":["News"],"articleSection":["General","News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/","url":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/","name":"Infarmed authorized Medicine for several types of cancer","isPartOf":{"@id":"https:\/\/els-solutions.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage"},"image":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png","datePublished":"2023-08-28T10:34:01+00:00","dateModified":"2024-02-20T16:24:08+00:00","description":"Infarmed has authorized the use of the medicine pembrolizumab for the treatment of several types of cancer.","breadcrumb":{"@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#primaryimage","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-Solutions-Infarmed-Innovative-Medicine-Cancer.png","width":1200,"height":600,"caption":"Infarmed Innovative Cancer Medicine"},{"@type":"BreadcrumbList","@id":"https:\/\/els-solutions.com\/en\/infarmed-authorized-innovative-medicine-for-several-types-of-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/els-solutions.com\/en\/"},{"@type":"ListItem","position":2,"name":"Infarmed authorized innovative medicine for several types of cancer"}]},{"@type":"WebSite","@id":"https:\/\/els-solutions.com\/en\/#website","url":"https:\/\/els-solutions.com\/en\/","name":"ELS Group - Accelerating Innovation","description":"Assessoria estrat\u00e9gia para a Ind\u00fastria Farmac\u00eautica","publisher":{"@id":"https:\/\/els-solutions.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/els-solutions.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/els-solutions.com\/en\/#organization","name":"ELS Group - Accelerating Innovation","url":"https:\/\/els-solutions.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","contentUrl":"https:\/\/els-solutions.com\/cms\/wp-content\/uploads\/2023\/08\/ELS-NewLogo-ColorBlack-1-e1691153715735.png","width":2226,"height":1080,"caption":"ELS Group - Accelerating Innovation"},"image":{"@id":"https:\/\/els-solutions.com\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/els.solutions\/"]},{"@type":"Person","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/9fb8dae537039679cfc537a000df6ca3","name":"Marketing ELS","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/els-solutions.com\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b785df1d10c9806cc43fcea2dbf585b96a8761ff697010979d603fc5b7a9ca7b?s=96&d=mm&r=g","caption":"Marketing ELS"},"sameAs":["https:\/\/els-solutions.com\/"]}]}},"_links":{"self":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5512","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/comments?post=5512"}],"version-history":[{"count":2,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5512\/revisions"}],"predecessor-version":[{"id":6560,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/posts\/5512\/revisions\/6560"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media\/5508"}],"wp:attachment":[{"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/media?parent=5512"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/categories?post=5512"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/els-solutions.com\/en\/wp-json\/wp\/v2\/tags?post=5512"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}